KEFLIN
LOE ApproachingNDAINJECTIONINJECTABLE
Approved
Dec 1974
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 21h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
KEFLIN is a small-molecule injectable antibiotic approved in 1974, representing a legacy Eli Lilly product now in its late lifecycle stage. The drug's specific mechanism and indications are not currently documented in available data, but its injectable formulation suggests use in acute or hospitalized patient populations. As an NDA-approved small molecule, it likely competes in a crowded antibiotic space with significant generic and newer-generation alternatives.
LOE Approaching
Product approaching loss of exclusivity with minimal linked job openings (0 roles), indicating a mature/wind-down commercial footprint.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
KEFLIN offers very limited career growth given zero linked job openings and approaching loss of exclusivity. Roles remaining are primarily defensive, focused on hospital contracts and managed care retention rather than expansion or innovation.
Hospital Account ManagerSales Representative
Worked on KEFLIN at Eli Lilly and Company? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.